Cumberland Pharmaceuticals Inc.
CPIX
$4.76
$0.235.08%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.90M | -1.54M | -1.09M | -1.95M | -6.29M |
| Total Depreciation and Amortization | 1.78M | 1.40M | 1.42M | 1.44M | 1.36M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -398.70K | -712.50K | -124.40K | -233.30K | 3.08M |
| Change in Net Operating Assets | 2.43M | 1.33M | -1.07M | -1.39M | 2.90M |
| Cash from Operations | 1.90M | 475.50K | -855.70K | -2.14M | 1.04M |
| Capital Expenditure | -2.30K | -15.40K | -7.20K | -41.60K | -48.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.50K | 205.00K | -39.60K | -16.60K | 309.30K |
| Cash from Investing | -26.80K | 189.60K | -46.80K | -58.20K | 260.60K |
| Total Debt Issued | 5.50M | 10.99M | 11.00M | 11.00M | 7.70M |
| Total Debt Repaid | -6.32M | -10.99M | -10.99M | -7.70M | -7.84M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -98.40K | -98.80K | -134.20K | -247.60K | -189.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -464.60K | -438.00K | -182.80K | -630.70K | -1.16M |
| Cash from Financing | -1.38M | -536.80K | -309.60K | 2.42M | -1.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 499.40K | 128.30K | -1.21M | 226.90K | -186.30K |